*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| D61810 - Antineoplastic chemotherapy induced pancytopenia - as a primary diagnosis code | D61810 - Antineoplastic chemotherapy induced pancytopenia - as a primary or secondary diagnosis code | |
|---|---|---|
| OUTCOMES | ||
| Avg. LOS | 9.56 | |
| Readmission Rate (%) | 34.26 | |
| Unplanned Readmission Rate (%) | 21.55 | |
| Mortality Rate (%) | ||
| SNF Discharge Rate (%) | ||
| Home Discharge Rate (%) | ||
| PAYMENTS AND CHARGES | ||
| Total Medicare Payments | ||
| Payment Per Day | ||
| Payment Per Hospitalization | ||
| Total Medicare Charges | ||
| Avg. Charges | ||
| MARKET SIZING & INCIDENCE RATES | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - All) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - All) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Yes) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Yes) | ||
| Total National Projected Hospitalizations - Annualized (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations - Oct 2015 to Sep 2018 (Present on Admission - Not Y) | ||
| Total Medicare Hospitalizations after Exclusion | ||
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 810: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITHOUT COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 802: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 981: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 45,432 | ||||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 8,108 | ||||
| DRG Share of Total Hospitalizations | 0.14 | ||||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 58.39 | ||||
| Avg LOS at DRG | 4.42 | ||||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 4.45 | ||||
| Readmission Rate at DRG | 30.74 | ||||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 33.17 | ||||
| Unplanned Readmission Rate at DRG | 18.94 | ||||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 21.04 | ||||
| Total Medicare payments at DRG | $376,347,273 | ||||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $63,731,494 | ||||
| Total Medicare payment per Day at DRG | $1,873 | ||||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,765 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,284 | ||||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $7,860 | ||||
| Total Medicare Charges at DRG | $1,794,383,177 | ||||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $308,571,230 | ||||
| Avg Charges at DRG | $39,496 | ||||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $38,058 | ||||
| Mortality Rate at DRG | 0.61 | ||||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 0.63 | ||||
| SNF Discharge Rate at DRG | 7.48 | ||||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 7.35 | ||||
| Home Discharge Rate at DRG | 67.79 | ||||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 64.79 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 987: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 803: OTHER O.R. PROCEDURES OF THE BLOOD AND BLOOD FORMING ORGANS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 982: EXTENSIVE O.R. PROCEDURE UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 988: NON-EXTENSIVE O.R. PROC UNRELATED TO PRINCIPAL DIAGNOSIS WITH COMPLICATION OR COMORBIDITY (CC) | |
|---|---|---|---|---|
| Total Hospitalizations at DRG | 33,583 | |||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 51 | |||
| DRG Share of Total Hospitalizations | 0.1 | |||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 0.37 | |||
| Avg LOS at DRG | 11.44 | |||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 18.2 | |||
| Readmission Rate at DRG | 33.65 | |||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 31.58 | |||
| Unplanned Readmission Rate at DRG | 21.15 | |||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | NA | |||
| Total Medicare payments at DRG | $802,022,870 | |||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,752,897 | |||
| Total Medicare payment per Day at DRG | $2,088 | |||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,889 | |||
| Total Medicare payment per Hospitalization at DRG | $23,882 | |||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $34,371 | |||
| Total Medicare Charges at DRG | $3,957,485,422 | |||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $10,718,045 | |||
| Avg Charges at DRG | $117,842 | |||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $210,158 | |||
| Mortality Rate at DRG | 8.73 | |||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 23.53 | |||
| SNF Discharge Rate at DRG | 24.87 | |||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | NA | |||
| Home Discharge Rate at DRG | 28.69 | |||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 33.33 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| MEMORIAL SLOAN KETTERING CANCER CENTER | 1275 YORK AVE | NEW YORK | NY | 10065 | 68 |
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 62 |
| ADVENTHEALTH ORLANDO | 601 E ROLLINS ST | ORLANDO | FL | 32803 | 50 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. WILLIAM SCOTT KELLOGG | 1105 N LAFAYETTE DR | SUMTER | SC | 29150 | 16 |
| Dr. RAMAKRISHNA BATTINI | 111 E 210TH ST | BRONX | NY | 10467 | 12 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. AMANDEEP KAUR DHATT | 200 CARMAN AVE | EAST MEADOW | NY | 11554 | 21 |
| Dr. SATINDERJIT S OBEROI | 902 N RIVERSIDE RD | SAINT JOSEPH | MO | 64507 | 18 |
| Dr. WILLIAM SCOTT KELLOGG | 1105 N LAFAYETTE DR | SUMTER | SC | 29150 | 17 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 871: SEPTICEMIA OR SEVERE SEPSIS WITHOUT MV >96 HOURS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 809: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH COMPLICATION OR COMORBIDITY (CC) | DRG 808: MAJOR HEMATOLOGICAL AND IMMUNOLOGICAL DIAGNOSES EXCEPT SICKLE CELL CRISIS AND COAGULATION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 016: AUTOLOGOUS BONE MARROW TRANSPLANT WITH COMPLICATION OR COMORBIDITY (CC)/MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 837: CHEMOTHERAPY WITH ACUTE LEUKEMIA AS SDX OR WITH HIGH DOSE CHEMOTHERAPY AGENT WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 1,808,415 | ||||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 21,995 | ||||
| DRG Share of Total Hospitalizations | 5.5 | ||||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 15.86 | ||||
| Avg LOS at DRG | 6.34 | ||||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 7.48 | ||||
| Readmission Rate at DRG | 24.2 | ||||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 30.98 | ||||
| Unplanned Readmission Rate at DRG | 16.78 | ||||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 19.89 | ||||
| Total Medicare payments at DRG | $21,288,214,047 | ||||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $289,668,816 | ||||
| Total Medicare payment per Day at DRG | $1,857 | ||||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,760 | ||||
| Total Medicare payment per Hospitalization at DRG | $11,772 | ||||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $13,170 | ||||
| Total Medicare Charges at DRG | $107,155,481,388 | ||||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,687,279,831 | ||||
| Avg Charges at DRG | $59,254 | ||||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $76,712 | ||||
| Mortality Rate at DRG | 12.11 | ||||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 12.98 | ||||
| SNF Discharge Rate at DRG | 27.18 | ||||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 13.55 | ||||
| Home Discharge Rate at DRG | 25.81 | ||||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 36.25 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 193: SIMPLE PNEUMONIA AND PLEURISY WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 846: CHEMOTHERAPY WITHOUT ACUTE LEUKEMIA AS SECONDARY DIAGNOSIS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 840: LYMPHOMA AND NON-ACUTE LEUKEMIA WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 834: ACUTE LEUKEMIA WITHOUT MAJOR O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 682: RENAL FAILURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 443,386 | ||||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 4,476 | ||||
| DRG Share of Total Hospitalizations | 1.35 | ||||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 3.23 | ||||
| Avg LOS at DRG | 5.27 | ||||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 6.07 | ||||
| Readmission Rate at DRG | 21.6 | ||||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 28.61 | ||||
| Unplanned Readmission Rate at DRG | 15.91 | ||||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 20.11 | ||||
| Total Medicare payments at DRG | $3,812,834,208 | ||||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $44,873,969 | ||||
| Total Medicare payment per Day at DRG | $1,632 | ||||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,651 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,599 | ||||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $10,025 | ||||
| Total Medicare Charges at DRG | $18,110,468,211 | ||||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $231,649,711 | ||||
| Avg Charges at DRG | $40,846 | ||||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $51,754 | ||||
| Mortality Rate at DRG | 3.59 | ||||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 3.22 | ||||
| SNF Discharge Rate at DRG | 22.57 | ||||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 9.2 | ||||
| Home Discharge Rate at DRG | 40.95 | ||||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 55.23 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 391: ESOPHAGITIS, GASTROENTERITIS AND MISCELLANEOUS DIGESTIVE DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 640: MISCELLANEOUS DISORDERS OF NUTRITION, METABOLISM , FLUIDS AND ELECTROLYTES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 393: OTHER DIGESTIVE SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 014: ALLOGENEIC BONE MARROW TRANSPLANT | DRG 853: INFECTIOUS AND PARASITIC DISEASES WITH O.R. PROCEDURE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 134,422 | ||||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 3,370 | ||||
| DRG Share of Total Hospitalizations | 0.41 | ||||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 2.43 | ||||
| Avg LOS at DRG | 4.97 | ||||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 5.76 | ||||
| Readmission Rate at DRG | 26.98 | ||||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 32.25 | ||||
| Unplanned Readmission Rate at DRG | 20.97 | ||||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 22.74 | ||||
| Total Medicare payments at DRG | $1,078,703,587 | ||||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $28,225,634 | ||||
| Total Medicare payment per Day at DRG | $1,614 | ||||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,454 | ||||
| Total Medicare payment per Hospitalization at DRG | $8,025 | ||||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $8,376 | ||||
| Total Medicare Charges at DRG | $5,564,930,414 | ||||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $157,629,224 | ||||
| Avg Charges at DRG | $41,399 | ||||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $46,774 | ||||
| Mortality Rate at DRG | 2.08 | ||||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 1.9 | ||||
| SNF Discharge Rate at DRG | 16.97 | ||||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 8.1 | ||||
| Home Discharge Rate at DRG | 52.45 | ||||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 62.05 |
*Readmission Rate is calculated from Oct 2015 to Aug 2018 and all other Quality Outcomes are calculated from Oct 2015 to Sep 2018.
| DRG 314: OTHER CIRCULATORY SYSTEM DIAGNOSES WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 377: G.I. HEMORRHAGE WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 180: RESPIRATORY NEOPLASMS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 291: HEART FAILURE AND SHOCK WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | DRG 308: CARDIAC ARRHYTHMIA AND CONDUCTION DISORDERS WITH MAJOR COMPLICATION OR COMORBIDITY (MCC) | |
|---|---|---|---|---|---|
| Total Hospitalizations at DRG | 138,345 | ||||
| Total Hospitalizations with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 2,130 | ||||
| DRG Share of Total Hospitalizations | 0.42 | ||||
| % of Total ICD D61810 - Antineoplastic chemotherapy induced pancytopenia in DRG | 1.54 | ||||
| Avg LOS at DRG | 6.92 | ||||
| Avg LOS with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 8.28 | ||||
| Readmission Rate at DRG | 32.2 | ||||
| Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 36.46 | ||||
| Unplanned Readmission Rate at DRG | 22.95 | ||||
| Unplanned Readmission Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 21.23 | ||||
| Total Medicare payments at DRG | $1,845,581,658 | ||||
| Total Medicare payments with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $32,742,939 | ||||
| Total Medicare payment per Day at DRG | $1,929 | ||||
| Total Medicare payment per Day with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $1,856 | ||||
| Total Medicare payment per Hospitalization at DRG | $13,340 | ||||
| Total Medicare payment per Hospitalization with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $15,372 | ||||
| Total Medicare Charges at DRG | $9,021,459,592 | ||||
| Total Medicare Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $175,344,740 | ||||
| Avg Charges at DRG | $65,210 | ||||
| Avg Charges with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | $82,321 | ||||
| Mortality Rate at DRG | 5.29 | ||||
| Mortality Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 5.26 | ||||
| SNF Discharge Rate at DRG | 18.8 | ||||
| SNF Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 11.83 | ||||
| Home Discharge Rate at DRG | 39.78 | ||||
| Home Discharge Rate with ICD D61810 - Antineoplastic chemotherapy induced pancytopenia | 39.81 |
| Hospital Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER | 1515 HOLCOMBE BLVD | HOUSTON | TX | 77030 | 1,589 |
| BARNES JEWISH HOSPITAL | 1 BARNES-JEWISH HOSPITAL PLZ | SAINT LOUIS | MO | 63110 | 1,383 |
| MAYO CLINIC HOSPITAL - SAINT MARYS CAMPUS | 1216 2ND ST SW | ROCHESTER | MN | 55902 | 1,022 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 158 |
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 150 |
| Dr. JAYESH MEHTA | 675 N SAINT CLAIR ST | CHICAGO | IL | 60611 | 118 |
| Physician Name | Address | City | State | Zip Code | Total Hospitalizations ( Oct 2015 to Sep 2018 ) |
|---|---|---|---|---|---|
| Dr. VIKAS BHUSHAN | 7777 FOREST LN | DALLAS | TX | 75230 | 269 |
| Dr. JEFFREY E BALL | 506 6TH ST | BROOKLYN | NY | 11215 | 186 |
| Dr. MELISSA LEIGH LARSON | 1725 W HARRISON ST | CHICAGO | IL | 60612 | 165 |